Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

The significance for chronic rejection of cardiac allograft of regulated upon activation normal T-cell cytokine and its CCR5 receptor.

Zhao H, Zhang Y, Song G, Zhao W, Bai X, Zhang J, Zhao X.

Transplant Proc. 2013 Mar;45(2):635-8. doi: 10.1016/j.transproceed.2012.03.065.

PMID:
23498802
[PubMed - indexed for MEDLINE]
2.

The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.

van Loosdregt J, van Oosterhout MF, Bruggink AH, van Wichen DF, van Kuik J, de Koning E, Baan CC, de Jonge N, Gmelig-Meyling FH, de Weger RA.

Circulation. 2006 Oct 10;114(15):1599-607. Epub 2006 Oct 2.

PMID:
17015796
[PubMed - indexed for MEDLINE]
Free Article
3.

Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.

Yun JJ, Whiting D, Fischbein MP, Banerji A, Irie Y, Stein D, Fishbein MC, Proudfoot AE, Laks H, Berliner JA, Ardehali A.

Circulation. 2004 Feb 24;109(7):932-7. Epub 2004 Feb 2.

PMID:
14757698
[PubMed - indexed for MEDLINE]
Free Article
4.

Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.

Yin R, Zhu J, Shao H, Cheng X, Feng X, Li Z, Jing H.

J Heart Lung Transplant. 2007 May;26(5):485-93.

PMID:
17449418
[PubMed - indexed for MEDLINE]
5.

Gene transfer of the S24F regulated on activation normal T-cell expressed and secreted-chemokine ligand 5 variant attenuates cardiac allograft rejection.

Sun Y, Feng J, Shi J, Lu X, Xie A, Chen Y, Dong N.

Transplantation. 2014 Jun 27;97(12):1233-9. doi: 10.1097/TP.0000000000000122.

PMID:
24825519
[PubMed - indexed for MEDLINE]
6.

Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.

Iida S, Omoto K, Kanemitsu I, Setoguchi K, Ishida H, Tanabe K, Suzuki T, Tashiro Y, Kishimoto H, Abe R.

Exp Clin Transplant. 2012 Aug;10(4):375-85. doi: 10.6002/ect.2011.0159. Epub 2012 Jul 2.

PMID:
22758208
[PubMed - indexed for MEDLINE]
Free Article
7.

Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.

Nozaki T, Amano H, Bickerstaff A, Orosz CG, Novick AC, Tanabe K, Fairchild RL.

J Immunol. 2007 Oct 15;179(8):5238-45.

PMID:
17911609
[PubMed - indexed for MEDLINE]
Free Article
8.

Role of regulated upon activation normal T-cell expressed and secreted in a model of retransplantation acute rejection mediated by alloreactive memory CD4+ T cells.

Zhou X, Shan Z, Liang H, Lin Z, Qiu S, Kuang F, Zhuang J, Qi Z.

Transplant Proc. 2013 Mar;45(2):546-51. doi: 10.1016/j.transproceed.2012.11.005.

PMID:
23498790
[PubMed - indexed for MEDLINE]
9.

CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.

Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, Turka LA, Russell ME, Peach R, Sayegh MH.

Am J Pathol. 2001 Mar;158(3):977-86.

PMID:
11238045
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.

Li J, Xia J, Zhang K, Xu L.

J Surg Res. 2009 Nov;157(1):81-90. doi: 10.1016/j.jss.2009.01.014. Epub 2009 Feb 14.

PMID:
19577762
[PubMed - indexed for MEDLINE]
11.

The effects of platelet-derived growth factor in rat cardiac allograft vasculopathy and fibrosis.

Song G, Fang Y, Wang X, Wu S, Song H.

Transplant Proc. 2008 Oct;40(8):2716-9. doi: 10.1016/j.transproceed.2008.07.119.

PMID:
18929844
[PubMed - indexed for MEDLINE]
12.

Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.

Amano H, Bickerstaff A, Orosz CG, Novick AC, Toma H, Fairchild RL.

J Immunol. 2005 May 15;174(10):6499-508.

PMID:
15879153
[PubMed - indexed for MEDLINE]
Free Article
13.

T cells infiltrating coronary arteries of cardiac allografts with chronic rejection contain clonally expanded T lymphocytes.

Slachta CA, Jeevanandam V, Goldman B, Platsoucas CD.

Transplant Proc. 1998 Jun;30(4):1002-4. No abstract available.

PMID:
9636405
[PubMed - indexed for MEDLINE]
15.

Beneficial effects of targeting CCR5 in allograft recipients.

Gao W, Faia KL, Csizmadia V, Smiley ST, Soler D, King JA, Danoff TM, Hancock WW.

Transplantation. 2001 Oct 15;72(7):1199-205.

PMID:
11602842
[PubMed - indexed for MEDLINE]
16.

The role of histoincompatibility in cardiac allograft vasculopathy.

Costanzo MR.

J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 2):S180-4. Review. No abstract available.

PMID:
8719482
[PubMed - indexed for MEDLINE]
17.

Increased connective tissue growth factor expression in a rat model of chronic heart allograft rejection.

Yuan YC, Xia ZK, Mu JJ, Zhang QC, Yin BL.

J Formos Med Assoc. 2009 Mar;108(3):240-6. doi: 10.1016/S0929-6646(09)60058-9.

PMID:
19293040
[PubMed - indexed for MEDLINE]
18.

Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1.

Nadeau KC, Azuma H, Tilney NL.

Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8729-33.

PMID:
7568006
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.

Solomon MF, Kuziel WA, Simeonovic CJ.

Cell Transplant. 2004;13(5):503-14.

PMID:
15565863
[PubMed - indexed for MEDLINE]
20.

Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection.

Miura M, Morita K, Kobayashi H, Hamilton TA, Burdick MD, Strieter RM, Fairchild RL.

J Immunol. 2001 Sep 15;167(6):3494-504.

PMID:
11544343
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk